title: Bladder cancer: Low adherence to guidelines in non-muscle-invasive disease.
authors: Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121,1066 CX, Amsterdam, The Netherlands; and the Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Landshuterstrasse 65, Regensburg 93053, Germany.
authors: Bas W G
authors: BW
authors: van Rhijn
authors: Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Landshuterstrasse 65, Regensburg 93053, Germany.
authors: Maximilian
authors: M
authors: Burger
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000283:Administration, Intravesical; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001500:BCG Vaccine / Q000008:administration & dosage*; D002277:Carcinoma / Q000175:diagnosis / Q000628:therapy*; D017326:Clinical Trials, Phase III as Topic; D018450:Disease Progression; D019317:Evidence-Based Medicine; D019983:Guideline Adherence; D017408:Guidelines as Topic; D006801:Humans; D009361:Neoplasm Invasiveness; D012955:Societies, Medical; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000628:therapy*
chemical_list: D000276:Adjuvants, Immunologic; D001500:BCG Vaccine